French HTA evalutions
04 May 2016
The French Haute Autorité de Santé is one of the HTA organisations in Europe with most publications. 3,6% of their publications are HTA reports and 96,4 % are reimbursement evaluations of individual drugs or technologies.
In the last 12 months, the 3 most frequent companies in the reports have been Sanofi, Pfizer and Roche.
Looking at their evaluations, there is a steady utility of quality of life measures such as EQ-5D and SF-36.
Learn more about our service: http://htasearch.synergus.com/